Suppr超能文献

大鼠远曲小管的适应性。II. 慢性噻嗪类输注的影响。

Adaptation of distal convoluted tubule of rats. II. Effects of chronic thiazide infusion.

作者信息

Morsing P, Velázquez H, Wright F S, Ellison D H

机构信息

Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut 06510.

出版信息

Am J Physiol. 1991 Jul;261(1 Pt 2):F137-43. doi: 10.1152/ajprenal.1991.261.1.F137.

Abstract

Mammalian distal tubules adapt structurally and functionally when NaCl concentration in tubule fluid is altered chronically. These experiments were designed to test the hypothesis that chronic administration of hydrochlorothiazide (HCTZ), a drug that blocks Na and Cl uptake across apical membranes of rat distal tubule cells, would reduce intrinsic transport capacity of distal tubules and reduce the number of thiazide-sensitive transporters. Osmotic pumps were implanted into rats to deliver 3.75 mg/day HCTZ or vehicle for 10-14 days. All animals were offered a solution containing 0.8% NaCl and 0.1% KCl as drinking fluid. Free-flow micropuncture after 10-14 days indicated that Na and Cl delivery to distal tubule was not significantly different in HCTZ- and vehicle-treated animals. Microperfusion in vivo with an artificial interstitial solution, with no thiazide, indicated that 10-14 days of HCTZ infusion did reduce Na transport capacity of distal tubules from 390 +/- 32 to 203 +/- 24 pmol/min (P less than 0.01). In contrast, the number of thiazide-sensitive NaCl transporters, determined as high-affinity receptors for [3H]metolazone in renal cortical membranes, was higher in HCTZ group than in controls (2.2 +/- 0.4 vs. 1.0 +/- 0.1 pmol/mg protein, P less than 0.01). These data support the hypothesis that chronic blockade of NaCl entry across apical membranes of distal tubule cells reduces NaCl transport capacity, an effect that occurs despite an increase in the number of thiazide receptors. They indicate that thiazide receptor binding studies should be interpreted in combination with direct functional measurements.

摘要

当肾小管液中的氯化钠浓度长期改变时,哺乳动物的远端小管会在结构和功能上发生适应性变化。这些实验旨在验证以下假设:长期给予氢氯噻嗪(HCTZ)这种能阻断大鼠远端小管细胞顶膜对钠和氯摄取的药物,会降低远端小管的固有转运能力,并减少噻嗪类敏感转运体的数量。将渗透泵植入大鼠体内,持续10 - 14天给予3.75毫克/天的氢氯噻嗪或赋形剂。所有动物饮用含0.8%氯化钠和0.1%氯化钾的溶液。10 - 14天后的自由流微穿刺结果表明,氢氯噻嗪处理组和赋形剂处理组动物远端小管的钠和氯输送量无显著差异。在无噻嗪类药物的人工间质溶液中进行体内微灌注实验表明,输注10 - 14天的氢氯噻嗪确实使远端小管的钠转运能力从390±32皮摩尔/分钟降至203±24皮摩尔/分钟(P<0.01)。相反,通过测定肾皮质膜中[³H]美托拉宗的高亲和力受体来确定的噻嗪类敏感氯化钠转运体数量,氢氯噻嗪组高于对照组(2.2±0.4对1.0±0.1皮摩尔/毫克蛋白,P<0.01)。这些数据支持了以下假设:长期阻断远端小管细胞顶膜对氯化钠的摄取会降低氯化钠转运能力,尽管噻嗪类受体数量增加,但这种影响依然会出现。它们表明噻嗪类受体结合研究应结合直接的功能测量结果进行解读。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验